Activist investor Politan Capital secured two board seats at medical technology company Masimo, ousting founder and CEO Joe ...

Masimo (MASI) stock rose 1.7% as activist investor Politan Capital secured two board seats after a contentious battle with ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles ...

Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today commented on the outcome of the Company's ...

Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from ...

The consensus estimate for this Zacks Rank #1 (Strong Buy) company’s 2024 sales is pegged at $8.1 billion, indicating a 13.7% ...

Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today issued ...

Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that leading proxy advisory firm Egan-Jones ...

Masimo is urging stockholders to vote “FOR” the Company’s director nominees, Joe Kiani and Christopher Chavez, on the updated GOLD proxy card to protect the Company and the value of their investment.